356 related articles for article (PubMed ID: 33031814)
1. Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy.
Boleti APA; Frihling BEF; E Silva PS; Cardoso PHO; de Moraes LFRN; Rodrigues TAA; Biembengute MEF; Koolen HHF; Migliolo L
Neurosci Biobehav Rev; 2022 Jan; 132():1214-1228. PubMed ID: 33031814
[TBL] [Abstract][Full Text] [Related]
2. Cannabis for the Treatment of Epilepsy: an Update.
Gaston TE; Szaflarski JP
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
[TBL] [Abstract][Full Text] [Related]
3. The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights.
Lazarini-Lopes W; Do Val-da Silva RA; da Silva-JĂșnior RMP; Leite JP; Garcia-Cairasco N
Neurosci Biobehav Rev; 2020 Apr; 111():166-182. PubMed ID: 31954723
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
[TBL] [Abstract][Full Text] [Related]
5. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
Reddy DS; Golub VM
J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
Golub V; Reddy DS
Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
[TBL] [Abstract][Full Text] [Related]
7. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
[TBL] [Abstract][Full Text] [Related]
8. Cannabis for Pediatric Epilepsy.
Huntsman RJ; Tang-Wai R; Shackelford AE
J Clin Neurophysiol; 2020 Jan; 37(1):2-8. PubMed ID: 31895184
[TBL] [Abstract][Full Text] [Related]
9. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
[TBL] [Abstract][Full Text] [Related]
10. Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy.
Anderson LL; Heblinski M; Absalom NL; Hawkins NA; Bowen MT; Benson MJ; Zhang F; Bahceci D; Doohan PT; Chebib M; McGregor IS; Kearney JA; Arnold JC
Br J Pharmacol; 2021 Dec; 178(24):4826-4841. PubMed ID: 34384142
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
[TBL] [Abstract][Full Text] [Related]
12. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.
Silvestro S; Mammana S; Cavalli E; Bramanti P; Mazzon E
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013866
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
14. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
Del Pozo A; Barker-Haliski M
Exp Neurol; 2023 Feb; 360():114288. PubMed ID: 36471511
[TBL] [Abstract][Full Text] [Related]
16. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
Reddy DS
Clin Pharmacol Ther; 2017 Feb; 101(2):182-184. PubMed ID: 27506704
[TBL] [Abstract][Full Text] [Related]
17. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
Lippiello P; Balestrini S; Leo A; Coppola A; Citraro R; Elia M; Russo E; De Sarro G
Curr Pharm Des; 2016; 22(42):6426-6433. PubMed ID: 27587196
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol and epilepsy: Rationale and therapeutic potential.
Leo A; Russo E; Elia M
Pharmacol Res; 2016 May; 107():85-92. PubMed ID: 26976797
[TBL] [Abstract][Full Text] [Related]
19. The case for assessing cannabidiol in epilepsy.
Cilio MR; Thiele EA; Devinsky O
Epilepsia; 2014 Jun; 55(6):787-90. PubMed ID: 24854434
[TBL] [Abstract][Full Text] [Related]
20. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP; Bebin EM
Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]